B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma

Cancer Research

Volumn 63, Issue 19, 2003, Pages 6501-6505

  Strome, Scott E ^a   Dong, Haidong ^b   Tamura, Hideto ^b   Voss, Stephen G ^a   Flies, Dallas B ^b   Tamada, Koji ^b   Salomao, Diva ^a   Cheville, John ^a   Hirano, Fumiya ^b   Lin, Wei ^a   Kasperbauer, Jan L ^a   Ballman, Karla V ^a   Chen, Lieping ^b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; MONOCLONAL ANTIBODY;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; CONTROLLED STUDY; GENETIC TRANSFECTION; HEAD AND NECK CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD80; BLOOD PROTEINS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; PEPTIDES; T-LYMPHOCYTES; TRANSFECTION;

EID: 0141953992     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Byers, R. M. Dr. Martin: how are we doing in 2000? Arch. Otolaryngol-Head Neck Surg., 127: 759-765, 2001.
2. Johansen, L. V., Grau, C., and Overgaard, J. Supraglottie carcinoma: patterns of failure and salvage treatment after curatively intended radiotherapy in 410 consecutive patients. Int. J. Radiat. Oncol. Biol. Phys., 53: 948-958, 2002.
3. Dong, H., Zhu, G., Tamada, K., and Chen, L. B7-H1, a third member of the B7 family, costimulates T-cell proliferation and interleukin-10 secretion. Nat. Med., 5: 1365-1369, 1999.
4. Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., Lennon, V. A., Celis, E., and Chen, L. Tumor-associated B7-H1 promotes T-cell apoptosis. A potential mechanism of immune evasion. Nat. Med., 8: 793-800, 2002.
5. Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chemova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., Horton, H. F., Fouser, L., Carter, L., Ling, V., Bowman, M. R., Carreno, B. M., Collins, M., Wood, C. R., and Honjo, T. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp Med., 192: 1027-1034, 2000.
6. Wang, S., Bajorath, J., Flies, D. B., Dong, H., Honjo, T., and Chen, L. Molelcular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction. J. Exp. Med, 197: 1083-1091, 2003.
7. Tamura, H., Dong, H., Zhu, G., Sica, G. L., Flies, D. B., Tamada, K., and Chen, L. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood, 97: 1809-1816, 2001.
8. Strome, S. E., Voss, S., Wilcox, R., Wakefield, T. L., Tamada, K., Flies, D., Chapoval, A., Lu, J., Kasperbauer, J. L., Padley, D., Vile, R., Gastineau, D., Wettstein, P., and Chen, L. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response. Cancer Res., 62: 1884-1889, 2002.
9. Strome, S. E., Krauss, J. C., Chang, A. E., and Shu, S. Strategies of lymphocyte activation for the adoptive immunotherapy of metastatic cancer: a review. J. Hematother., 2: 63-73, 1993.
10. Strome, S. E., Martin, B., Flies, D., Tamada, K., Chapoval, A. I., Sargent, D. J., Shu, S., and Chen, L. Enhanced therapeutic potential of adoptive immunotherapy by in vitro CD28/4-1BB costimulation of tumor-reactive T cells against a poorly immunogenic, major histocompatibility complex class I-negative A9P melanoma. J. Immunother., 23: 430-437, 2000.
11. Khurana, D., Martin, E., O'Malley, B., Chen, L., and Strome, S. Characterization of a spontaneously arising murine squamous cell carcinoma (SCC VII) as a prerequisite for head and neck cancer immunotherapy. Head Neck, 23: 332-339, 2001.
12. Iwai, Y., Ishida, M., Tanaka, Y., Okazaki, T., Honjo, T., and Minato, N. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc. Natl. Acad. Sci. USA, 99: 12293-12297, 2002.